Sage CEO hopes for a Prozac moment with experimental depression drug By: CNBC.com News December 08, 2017 at 13:33 PM EST Sage Therapeutics CEO Jeff Jonas hopes a drug in development for major depressive disorder will be as big as Prozac. Read More >> Related Stocks: Sage Therapeutic Com